title: Malate and lactate dehydrogenases of a freshwater catfish: impact of endosulfan.
abstract: A sublethal concentration of technical grade endosulfan (END) inhibited 35 to 55% of the activities of cytoplasmic malate dehydrogenase (cMDH), mitochondrial malate dehydrogenase (mMDH), and lactate dehydrogenase (LDH) in the liver and the skeletal muscle of a freshwater catfish, Clarias batrachus, after 7 days of exposure. The activity remained in the inhibited state up to 28 days. The withdrawal of END from the medium after 1 week of exposure gradually restored the activities to control levels within 21 days in the skeletal muscle and 28 days in the liver. The administration of actinomycin D or cycloheximide between the 14th and the 21st day of the withdrawal of END almost completely inhibited the withdrawal-dependent recovery in the activities of all the three enzymes. This indicates de novo synthesis of the enzymes during the recovery period. A conjoint treatment of END and triiodothyronine (T3) raised the activities of cMDH, mMDH, and LDH in the liver and the skeletal muscle up to the control levels. This shows that the inhibitory effect of END may be relieved in presence of T3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed few changes in the pattern of cytoplasmic proteins of the liver and the skeletal muscle in response to exposure to END.
authors.affiliation: Department of Zoology, Banaras Hindu University, Varanasi, India.
authors.forename: G
authors.initials: G
authors.lastname: Tripathi
authors.forename: S P
authors.initials: SP
authors.lastname: Shukla
mesh_terms: D000818:Animals; D002397:Catfishes; D003513:Cycloheximide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004591:Electrophoresis, Polyacrylamide Gel; D004726:Endosulfan / Q000633:toxicity*; D005260:Female; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008291:Malate Dehydrogenase / Q000378:metabolism*; D008297:Male; D009132:Muscles / Q000187:drug effects* / Q000378:metabolism; D014284:Triiodothyronine / Q000627:therapeutic use
chemical_list: D014284:Triiodothyronine; D003609:Dactinomycin; D003513:Cycloheximide; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D004726:Endosulfan